CDC warns severe flu season; urges Tamiflu, Relenza use
This article was originally published in Scrip
With a vaccine that has turned out to be a poor match for the strain that is predominant this season in the US – influenza A (H3N2) – and an anticipated bad year for the virus, the Centers for Disease Control and Prevention is urging doctors not to wait for test results if the disease is suspected before prescribing antivirals.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.